Elon Musk admitted using weight loss medications, facing backlash on social media. He posted a picture of himself on X dressed as Santa Claus calling himself the “Ozempic Santa“, as he appears slimmer. Social media users erupted in outrage over the widespread use of a popular drug, originally developed to treat serious illnesses as diabete, now favored by Hollywood elites and others who can afford it to achieve effortless weight loss.
Elon Musk net worth hits $400 billion, setting a new record in personal wealth
His post on X
The discussion around weight loss drugs has sparked a heated debate in the United States, blending politics, healthcare, and personal choices. That’s why Elon Musk’s post admitting his use of the weight loss drug Mounjaro drew intense attention.
Ozempic Santa pic.twitter.com/7YECSNpWoz
— Elon Musk (@elonmusk) December 26, 2024
President Joe Biden announced plans to include these medications under medical insurance coverage, while a future Trump cabinet member countered with a proposal for free gym access instead.
Biden and weight loss drugs: «They will be covered by medical insurance». The future Trump minister says no: «Better free gyms». Musk clarifies that he uses the medication called Mounjaro, which has the same principle as Ozempic, because «it has fewer side effects and is more effective». The billionaire has long argued that drugs like Ozempic can help combat the obesity epidemic in the United States. This position puts him at odds with Robert F. Kennedy Jr., who believes that a healthy diet is the most economical key to tackling the problem.
What is Ozempic?
Ozempic and other drugs in the same class, like Mounjaro, are approved by the Food and Drug Administration for diabetes (other medications like Zepbound and Wegovy have also received the green light for weight loss), but they are frequently prescribed off-label. They are also very expensive medications and rarely covered by insurance, resulting in access being limited to those who can afford to pay a thousand dollars a month, the price of four weekly injections. According to the European Medicines Agency (EMA), Ozempic is «an antidiabetic drug used in combination with diet and exercise to treat adults with type 2 diabetes that is not satisfactorily controlled».
The drug can be used «as monotherapy (alone) in patients who cannot take metformin (another antidiabetic drug). It can also be used in combination with other antidiabetic medications». Ozempic can have side effects such as «digestive issues, including diarrhea, vomiting, and nausea» as well as «a severe worsening of diabetic retinopathy». But the real risk comes from the uncontrolled use of the drug, not paired with physical activity and a proper diet.
© ALL RIGHTS RESERVED
‘;
outbrainEl.insertAdjacentHTML(“afterBegin”, AdCodeOutbrain);
loadScript(‘//widgets.outbrain.com/outbrain.js’, function(){
// cerco il widget. Necessario se c’è un’altro widget di Outbrain in pagina (es: inread)
OBR.extern.researchWidget();
});
}
function AnnunciOutbrain(callback) {
var outbrainDiv = document.getElementById(‘outbrainWait’);
// Verifica se l’elemento esiste
if (outbrainDiv) {
// Modifica l’id dell’elemento div
outbrainDiv.id = ‘outbrain’;
}
var load_method = impostazioni_testata.outbrain.load_method || ‘first-interaction’;
var outbrainEl = document.getElementById(‘outbrain’);
CED.log(“outbrain load_method:” + load_method);
if (load_method == ‘when-near-viewport’) {
// outbrain parte solo quando scrollando arriva abbastanza vicino alla viewport
if (typeof callback === “function”) {
// Listen for the scroll event
//document.addEventListener(‘scroll’, onScroll(outbrainEl,callback), false);
CedsWNV.watch(outbrainEl, callback, {
checkInterval: 300,
offset: 500
});
/*devo chiamare la funzione con argomenti e variabili */
}
} else {
// DEFAULT: outbrain parte alla prima interazione o dopo il timeout inattività
_waitOnceFor(load_method, callback);
}
}
AnnunciOutbrain(WidgetOutbrainTag);